University Glaucoma Center is categorized under Ophthalmologists in Tampa, FL and active since 1992.
University Glaucoma Center was established in 1992, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Ophthalmologists business, which does work in the B2C market, and is classified as a Ophthalmologists, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Jennifer Byrd, Administrator at the company’s single location by writing to 4444 East Fletcher Avenue # D, Tampa, Florida FL 33613 or by phoning (813) 972-9040. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | University Glaucoma Center |
| Contact Person: | Jennifer Byrd, Administrator |
| Address: | 4444 East Fletcher Avenue # D, Tampa, Florida 33613 |
| Phone Number: | (813) 972-9040 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1992 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Ophthalmologists |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
University Glaucoma Center was started in 1992 to provide professional Ophthalmologists under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Jennifer Byrd, Administrator for inquiries that concern University Glaucoma Center by calling the company number (813) 972-9040, as your correspondence is most welcome. Additionally, the physical location of the single location of University Glaucoma Center can be found at the coordinates 28.06922,-82.41106 as well as the street address 4444 East Fletcher Avenue # D in Tampa, Florida 33613.
For its online presence, you may visit University Glaucoma Center’s website at and engage with its social media outlets through on Twitter and on Facebook.